Medifoxamine (Standard)

Overview

Medifoxamine (Standard) is the analytical standard of Medifoxamine ( HY-119468 ). This product is intended for research and analytical applications. Medifoxamine is an orally active monoamine reuptake inhibitor and antidepressant. Medifoxamine preferentially inhibits presynaptic dopamine reuptake. Medifoxamine acts as an intraocular pressure-lowering agent to reduce intraocular pressure, and also functions as a miotic agent to decrease pupil diameter. Medifoxamine exhibits characteristic properties of antidepressant compounds, including preventing hypothermia induced by Reserpine ( HY-N0480 ) or Apomorphine ( HY-12723 ), potentiating the toxic effects of Yohimbine ( HY-N0127 ) in mice, and reducing immobility behavior in mice and rats in the "behavioral despair" model. Medifoxamine has no anticholinergic activity. Medifoxamine can be used in research related to depression.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Visual System Disease | Products > Disease Areas > Depression | Products > Disease Areas > Ocular Hypertension | Products > Signaling Pathways > Others | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > Dopamine Transporter

Product Information

• Catalog No.: HY-119468R
• CAS No.: 32359-34-5
• Molecular Formula: C16H19NO2
• Molecular Weight: 257.33
• Purity: 98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source